2010 provocative agents

  1. 1,617 Posts.
    lightbulb Created with Sketch. 301
    MM&M's pipeline draws from the best drugs in development, profiling 15 agents with the highest approval rating and brightest commercial prospects. These are the prime near-term launch candidates. The report also provides updates on 202 products in a host of theraputic areas.

    ...

    OTHER KEY PRODUCTS IN THE PIPELINE

    APRICITABINE Avexa
    HIV Infection (Ph. III)


    Only other new HIV ART drugs mentioned
    Viciviroc Merck
    Rilpivirine Tibotec

    http://media.mmm-online.com/documents/12/pipeline2010_2759.pdf
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.